Antagonizing c-Cbl enhances EGFR-dependent corneal epithelial homeostasis

Investigative Ophthalmology and Visual Science

Volumn 55, Issue 8, 2014, Pages 4691-4699

  Rush, Jamie S ^a   Boeving, Michael A ^b   Berry, William L ^b   Ceresa, Brian P ^a,b  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

Corneal epithelium; Corneal wound healing; EGFR; Endocytic trafficking

Indexed keywords

4 AMINO 7 TERT BUTYL 5 (4 METHYLPHENYL) PYRAZOLO [3, 4 D] PYRIMIDINE; CBL PROTEIN; DOXYCYCLINE; EPIDERMAL GROWTH FACTOR RECEPTOR; EYE DROPS; IODINE 125; PHOSPHOTYROSINE; RADIOLIGAND; UBIQUITIN; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ARTICLE; CELL LYSATE; CELL MIGRATION; CONTROLLED STUDY; CORNEA EPITHELIUM; CULTURE MEDIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GENE SILENCING; HOMEOSTASIS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; LENTIVIRUS INFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS INHIBITION; RNA INTERFERENCE; UBIQUITINATION; WOUND HEALING;

CORNEAL EPITHELIUM; CORNEAL WOUND HEALING; EGFR; ENDOCYTIC TRAFFICKING;

ANIMALS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIUM, CORNEAL; EYE INJURIES; FEMALE; HOMEOSTASIS; HUMANS; IMMUNOBLOTTING; MICE; MICE, INBRED C57BL; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-CBL; PYRAZOLES; PYRIMIDINES; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; UBIQUITINATION; WOUND HEALING;

EID: 84905220084     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.14-14133     Document Type: Article

References (41)

1. Johnson KS, Levin F, Chu DS. Persistent corneal epithelial defect associated with erlotinib treatment. Cornea. 2009; 28: 706-707.
2. Oliva MS, Schottman T, Gulati M. Turning the tide of corneal blindness. Indian J Ophthalmol. 2012; 60: 423-427.
3. Rosenberg ME, Tervo TM, Immonen IJ, Muller LJ, Gronhagen-Riska C, Vesaluoma MH. Corneal structure and sensitivity in type 1 diabetes mellitus. Invest Ophthalmol Vis Sci. 2000; 41: 2915-2921.
4. Whitcher JP, Srinivasan M, Upadhyay MP. Corneal blindness: a global perspective. Bull World Health Organ. 2001; 79: 214-221.
5. Imanishi J, Kamiyama K, Iguchi I, Kita M, Sotozono C, Kinoshita S. Growth factors: importance in wound healing and maintenance of transparency of the cornea. Prog Retin Eye Res. 2000; 19: 113-129.
6. Zieske JD, Takahashi H, Hutcheon AEK, Dalbone AC. Activation of epidermal growth factor receptor during corneal epithelial migration. Invest Opthalmol Vis Sci. 2000; 41: 1346-1355.
7. Foerster CG, Cursiefen C, Kruse FE. Persisting corneal erosion under cetuximab (Erbitux) treatment (epidermal growth factor receptor antibody). Cornea. 2008; 27: 612-614.
8. Daniele S, Frati L, Fiore C, Santoni G. The effect of the epidermal growth factor (EGF) on the corneal epithelium in humans. Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1979; 210: 159-165.
9. Dellaert MM, Casey TA, Wiffen S, et al. Influence of topical human epidermal growth factor on postkeratoplasty reepithelialisation. Br J Ophthalmol. 1997; 81: 391-395.
10. Kandarakis AS, Page C, Kaufman HE. The effect of epidermal growth factor on epithelial healing after penetrating keratoplasty in human eyes. Am J Ophthalmol. 1984; 98: 411-415.
11. Pastor JC, Calonge M. Epidermal growth factor and corneal wound healing. A multicenter study. Cornea. 1992; 11: 311-314.
12. Ceresa BP. Spatial regulation of epidermal growth factor receptor signaling by endocytosis. Int J Mol Sci. 2012; 14: 72-87.
13. Peterson JL, Phelps ED, Doll MA, Schaal S, Ceresa BP. Analysis of EGFR ligands found in human tears reveals differences in corneal epithelial wound healing and ligand induced EGFR signaling. Invest Ophthalmol Vis Sci. 2014; 55: 2870-2880.
14. Sorkin A, Goh LK. Endocytosis and intracellular trafficking of ErbBs. Exp Cell Res. 2009; 315: 683-696.
15. McClintock JL, Ceresa BP. Transforming growth factor-a (TGFa) enhances corneal epithelial cell migration by promoting EGFR recycling. Invest Ophthalmol Vis Sci. 2010; 51: 3455-3461.
16. Wang YN, Yamaguchi H, Hsu JM, Hung MC. Nuclear trafficking of the epidermal growth factor receptor family membrane proteins. Oncogene. 2010; 29: 3997-4006.
17. Liao HJ, Carpenter G. Role of the Sec61 translocon in EGF receptor trafficking to the nucleus and gene expression. Mol Biol Cell. 2007; 18: 1064-1072.
18. Opresko LK, Chang CP, Will BH, Burke PM, Gill GN, Wiley HS. Endocytosis and lysosomal targeting of epidermal growth factor receptors are mediated by distinct sequences independent of the tyrosine kinase domain. J Biol Chem. 1995; 270: 4325-4333.
19. Babst M, Odorizzi G, Estepa EJ, Emr SD. Mammalian tumor susceptibility gene 101 (TSG101) and the yeast homologue, Vps23p, both function in late endosomal trafficking. Traffic. 2000; 1: 248-258.
20. Razi M, Futter CE. Distinct roles for Tsg101 and Hrs in multivesicular body formation and inward vesiculation. Mol Biol Cell. 2006; 17: 3469-3483.
21. Vanlandingham PA, Ceresa BP. Rab7 regulates late endocytic trafficking downstream of multivesicular body biogenesis and cargo sequestration. J Biol Chem. 2009; 284: 12110-12124.
22. Joazeiro CAP, Wing SS, Huang H-K, Leverson JD, Hunter T, Liu Y-C The tyrosine kinase negative regulator c-Cbl as a RINGType, E2-dependent ubiquitin-protein ligase. Science. 1999; 286: 309-312.
23. Caligiuri MA, Briesewitz R, Yu J, et al. Novel c-CBL and CBL-b ubiquitin ligase mutations in human acute myeloid leukemia. Blood. 2007; 110: 1022-1024.
24. Robertson DM, Li L, Fisher S, et al. Characterization of growth and differentiation in a telomerase-immortalized human corneal epithelial cell line. Invest Ophthalmol Vis Sci. 2005; 46: 470-478.
25. Olson A, Sheth N, Lee JS, Hannon G, Sachidanandam R. RNAi codex: a portal/database for short-hairpin RNA (shRNA) genesilencing constructs. Nucleic Acids Res. 2006; 34: D153-D157.
26. Shin KJ, Wall EA, Zavzavadjian JR, et al. A single lentiviral vector platform for microRNA-based conditional RNA interference and coordinated transgene expression. Proc Natl Acad Sci U S A. 2006; 103: 13759-13764.
27. Rush JS, Quinalty LM, Engelman L, Sherry DM, Ceresa BP. Endosomal accumulation of the activated epidermal growth factor receptor (EGFR) induces apoptosis. J Biol Chem. 2012; 287: 712-722.
28. Visser Smit GD, Place TL, Cole SL, et al. Cbl controls EGFR fate by regulating early endosome fusion. Sci Signal. 2009; 2: ra86.
29. Sharma GD, He J, Bazan HE. p38 and ERK1/2 coordinate cellular migration and proliferation in epithelial wound healing: evidence of cross-talk activation between MAP kinase cascades. J Biol Chem. 2003; 278: 21989-21997.
30. Xu K-P, Ding Y, Ling J, Dong Z, Yu F-S. Wound-induced HB-EGF ectodomain shedding and EGFR activation in corneal epithelial cells. Invest Ophthalmol Vis Sci. 2004; 45: 813-820.
31. Yoshioka R, Shiraishi A, Kobayashi T, et al. Corneal epithelial wound healing impaired in keratinocyte-specific HB-EGFdeficient mice in vivo and in vitro. Invest Ophthalmol Vis Sci. 2010; 51: 5630-5639.
32. Amoui M, Draber P, Draberova L. Src family-selective tyrosine kinase inhibitor, PP1, inhibits both Fc epsilonRI-and Thy-1-mediated activation of rat basophilic leukemia cells. Eur J Immunol. 1997; 27: 1881-1886.
33. Kassenbrock CK, Hunter S, Garl P, Johnson GL, Anderson SM. Inhibition of Src family kinases blocks epidermal growth factor (EGF)-induced activation of Akt, phosphorylation of c-Cbl, and ubiquitination of the EGF receptor. J Biol Chem. 2002; 277: 24967-24975.
34. Rutten MJ, Dempsey PJ, Luttropp CA, et al. dentification of an EGF/TGF-alpha receptor in primary cultures of guinea pig gastric mucous epithelial cells. Am J Physiol. 1996; 270: G604-G612.
35. Longva KE, Blystad FD, Stang E, Larsen AM, Johannessen LE, Madshus IH. Ubiquitination and proteasomal activity is required for transport of the EGF receptor to inner membranes of multivesicular bodies. J Cell Biol. 2002; 156: 843-854.
36. Gao CY, Stepp MA, Fariss R, Zelenka P. Cdk5 regulates activation and localization of Src during corneal epithelial wound closure. J Cell Sci. 2004; 117: 4089-4098.
37. Xu K-P, Yin J, Yu F-S. Src-family tyrosine kinases in wound-and ligand-induced epidermal growth factor receptor activation in human corneal epithelial cells. Invest Ophthalmol Vis Sci. 2006; 47: 2832-2839.
38. Garcia-Guzman M, Larsen E, Vuori K. The proto-oncogene c-Cbl is a positive regulator of Met-induced MAP kinase activation: a role for the adaptor protein Crk. Oncogene. 2000; 19: 4058-4065.
39. Yokouchi M, Wakioka T, Sakamoto H, et al. APS, an adaptor protein containing PH and SH2 domains, is associated with the PDGF receptor and c-Cbl and inhibits PDGF-induced mitogenesis. Oncogene. 1999; 18: 759-767.
40. Takahashi Y, Shimokawa N, Esmaeili-Mahani S, et al. Ligandinduced downregulation of TrkA is partly regulated through ubiquitination by Cbl. FEBS Lett. 2011; 585: 1741-1747.
41. Kimura Y, Tanaka K. Regulatory mechanisms involved in the control of ubiquitin homeostasis. J Biochem. 2010; 147: 793-798.